Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework

Certification ensures highest level of patient data security a medical device can attain

• Effective 7/14/2025 and expiring on 7/14/2028 under eMASS System ID #4060

TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ -- Today Dräger, an international leader in medical and safety technologies, announced that the company's Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #4060.

"Cyberattacks continue to be a serious threat to hospitals – both clinically and financially," said President and CEO for Draeger, Inc., Lothar Thielen. "To help hospitals meet this challenge, Dräger embeds the latest cybersecurity technology deeply into our development processes. Our new Atlan anesthesia workstations now carry ATO certification, which is the highest level of security a medical device can hold."

Continuing a longstanding commitment to patient data security
Certification of Dräger's Atlan A350/A350XL anesthesia workstation follows the certifications of the Perseus A500 (eMASS # 2852) and Fabius MRI (eMASS # 2875) anesthesia workstations.  Now with the Atlan certification, Dräger anesthesia customers can have confidence knowing that Dräger's entire anesthesia machine portfolio has gone through this rigorous cyber-security review process.

Benefits of ATO-certified medical devices
Medical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including:

• Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations
• Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues
• Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments
• Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness
• Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time
• Faster installation: ATO-certified devices streamline the process of integrating device data with electronic medical records, centralized alarm stations, and remote notifications

These benefits enable ATO-certified medical devices to provide stronger patient data protection and carry a lower risk of cyberattacks.  

More information:
Dräger Atlan A350/A350 XL family of devices:
https://www.draeger.com/en-us_us/Products/Atlan-A350-US-Version

You can find more information and pictures in our press center:
https://www.draeger.com/en-us_us/Newsroom/Press-Center

Dräger. Technology for Life.
Dräger is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3,4 billion in 2024. The Lübeck-based company is represented in more than 190 countries and employs more than 16,000 people worldwide. For more information, visit www.draeger.com

Contact
Communications: Melanie Kamann, Tel. +49 451 882-3202, [email protected] 
Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, [email protected] 
Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, [email protected] 

SOURCE Draeger